• An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study 

      Vals-Delgado, Cristina; Alcalá-Diaz, Juan F.; Molina-Abril, Helena; Roncero-Ramos, Irene; Caspers, Martien P.M.; Schuren, Frank H.J.; Broek, Tim J. Van den; Luque, Raúl M.; Pérez-Martínez, Pablo; Katsiki, Niki; Delgado-Lista, Javier; Ordovas, José M.; Ommene, Ben van; Camargo García, A.; López-Miranda, José (Elsevier, 2021)
      Introduction. A distinctive gut microbiome have been linked to type 2 diabetes mellitus (T2DM). We aimed to evaluate whether gut microbiota composition, in addition to clinical biomarkers, could improve the prediction of ...
    • Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial 

      Roncero-Ramos, Irene; Gutiérrez Mariscal, Francisco Miguel; Gómez Delgado, Francisco; Villasanta-González, Alejandro; Torres‑Peña, J.D.; Cruz‐Ares, Silvia de la; Rangel Zúñiga, Oriol Alberto; Luque, Raúl M.; Ordovas, José M.; Delgado-Lista, Javier; Pérez-Martínez, Pablo; Camargo García, A.; Alcalá Díaz, Juan Francisco; López-Miranda, José (Elsevier, 2021)
      In order to assess whether previous hepatic IR (Hepatic-IR fasting) and beta-cell functionality could modulate type 2 diabetes remission and the need for starting glucose- lowering treatment, newly-diagnosed type 2 diabetes ...